Global Cancer Monoclonal Antibodies Market Share

Market Share of Global Cancer Monoclonal Antibodies Industry

The cancer monoclonal antibodies market is highly consolidated. Some of the companies which are currently dominating the market are Amgen Inc., Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Genmab AS, GlaxoSmithKline PLC, Johnson & Johnson, Novartis AG, Seattle Genetics Inc., and Spectrum Pharmaceuticals Inc., among others, hold the substantial market share in the market studied.

Cancer Monoclonal Antibodies Market Leaders

1. Amgen Inc

2. Eli Lilly and Company

3. F. Hoffmann-La Roche Ltd (Genentech Inc)

4. Merck & Co., Inc

5. Novartis AG

*Disclaimer: Major Players sorted in no particular order